Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
01-Jun-2026 | 780 | 793 | 770.6 | 779 | 28,871 | 58,60,93,872.6 | 3,61,821 |
02-Jun-2026 | 779.5 | 787.25 | 768.75 | 777.55 | 18,055 | 33,21,77,852.15 | 2,30,769 |
03-Jun-2026 | 782 | 797 | 780.45 | 793.8 | 21,736 | 60,77,07,832.8 | 3,29,548 |
04-Jun-2026 | 794.75 | 797.4 | 781.6 | 791.35 | 18,649 | 39,93,26,091.2 | 2,77,122 |
05-Jun-2026 | 797 | 797.9 | 777.35 | 789.85 | 19,666 | 46,69,67,402.35 | 3,34,665 |
08-Jun-2026 | 775 | 797.5 | 761 | 766.35 | 21,423 | 42,80,60,075.55 | 3,23,983 |
09-Jun-2026 | 767 | 779 | 757.1 | 765.05 | 22,802 | 45,68,88,987.65 | 3,25,253 |
10-Jun-2026 | 769.9 | 780 | 760 | 760.8 | 27,423 | 1,20,35,39,360.3 | 6,54,919 |
11-Jun-2026 | 756.5 | 780.9 | 751 | 763.15 | 27,159 | 67,46,60,766.05 | 4,19,408 |
12-Jun-2026 | 770 | 778.95 | 763.1 | 766.45 | 17,493 | 26,97,20,980.5 | 1,83,584 |
15-Jun-2026 | 769.95 | 772 | 739.85 | 748.5 | 48,534 | 97,24,19,152.9 | 6,40,164 |
16-Jun-2026 | 748.55 | 757 | 745.2 | 748.35 | 25,194 | 1,45,41,05,529.75 | 13,36,004 |
17-Jun-2026 | 752 | 758.65 | 736.5 | 741.4 | 24,838 | 60,78,29,203.55 | 4,47,597 |
18-Jun-2026 | 742.6 | 784.85 | 740.55 | 782.1 | 37,274 | 1,24,38,81,663.55 | 9,53,362 |
19-Jun-2026 | 778.2 | 795.6 | 771.35 | 786.9 | 43,408 | 1,40,38,16,109 | 8,84,585 |
22-Jun-2026 | 790 | 797 | 775.1 | 778.4 | 15,164 | 29,28,98,034.25 | 1,60,508 |
23-Jun-2026 | 789 | 803.9 | 785 | 788 | 69,083 | 1,28,58,75,623.7 | 8,28,052 |
24-Jun-2026 | 789.65 | 799.9 | 767.25 | 770.85 | 27,986 | 65,30,44,123.3 | 4,39,690 |
25-Jun-2026 | 774.5 | 781.9 | 758.5 | 764.2 | 20,269 | 42,59,40,121.95 | 2,74,734 |
These include the Ascelis Center of Excellence for Peptide Development and Characterization and the Granules Center of Excellence for Particle Engineering.
Here are some of the stocks that may see significant price movement today.: Hindustan Aeronautics, BEL, Waaree Renewable, etc.
The five-day inspection ran from June 16 to June 20, 2025
The firm’s net debt fell by ₹136 crore to ₹706.1 crore, with a comfortable net debt-to-EBITDA at 0.75x
The pharma company caters to various international markets, reinforcing its position as a key player in the pharmaceutical industry.
Granules India, maintaining that it fully intends to respond in the time period allowed, as well as requesting a meeting with the FDA to show progress made in compliance, has taken care to make this clear as well.
The inspection covered Active Pharmaceutical Ingredients (APIs) and Finished Dosages (FDs) for oncology and non-oncology segments, underscoring the plant’s adherence to high manufacturing standards.
Bupropion hydrochloride is widely prescribed for treating major depressive disorder (MDD) and preventing seasonal affective disorder (SAD).
The USFDA has also noted a repeat observation from the company's January 2023 inspection.
Glycopyrrolate Oral Solution is an anticholinergic medication used to treat pediatric patients aged 3 to 16 years with neurological conditions that cause drooling.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
